Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by The Michael J. Fox Foundation for Parkinson’s Research. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Michael J. Fox Foundation for Parkinson’s Research or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Investigating Light Therapy For Sleep and Motor Function in People with PD with Beatrix Feigl

42:03
 
Share
 

Manage episode 465468416 series 2456444
Content provided by The Michael J. Fox Foundation for Parkinson’s Research. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Michael J. Fox Foundation for Parkinson’s Research or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Sleep disturbances, such as insomnia, sleep fragmentation, excessive daytime sleepiness, and REM sleep behavior disorder are common in people with Parkinson's disease (PD). Poor sleep quality can also impact other domains of function, including motor function. Prior research has shown that a type of photoreceptor cell in the retina, called melanopsin cells, provide the main light signals to the brain to initiate sleep, and function of these cells is impaired in PD. Dr. Beatix Feigl and her colleagues developed a novel light therapy intervention that selectively activates the melanopsin photoreceptor cells, and in this episode, she discusses the results of a recent randomized controlled trial evaluating the efficacy of this melanopsin photoreceptor-directed light therapy on sleep and circadian rhythm, as well as motor behaviors. She also discusses her earlier work on melanopsin cells that led to the development of standard measures to assess their function. Beatrix is an Ophthalmologist and an Associate Professor in the School of Biomedical Sciences and Center for Vision and Eye Research, as well as the Faculty of Health, at the Queensland University of Technology.

Mentioned in this episode:

From now through December 2, you can help accelerate Parkinson’s research. This Giving Tuesday, all donations to The Michael J. Fox Foundation will be matched up to $4 million, which means your impact will be doubled. Visit michaeljfox.org/givetoresearch to be part of the cure.

This podcast episode was part of a limited series created by The Michael J. Fox Foundation in 2023 and 2024 for clinicians and researchers in our audience. These episodes provide a deeper dive into exciting new scientific research in Parkinson’s disease, as well as innovative tools and valuable resources, through conversations with a variety of experts in the field. We hope you enjoy the conversation.

  continue reading

256 episodes

Artwork
iconShare
 
Manage episode 465468416 series 2456444
Content provided by The Michael J. Fox Foundation for Parkinson’s Research. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Michael J. Fox Foundation for Parkinson’s Research or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Sleep disturbances, such as insomnia, sleep fragmentation, excessive daytime sleepiness, and REM sleep behavior disorder are common in people with Parkinson's disease (PD). Poor sleep quality can also impact other domains of function, including motor function. Prior research has shown that a type of photoreceptor cell in the retina, called melanopsin cells, provide the main light signals to the brain to initiate sleep, and function of these cells is impaired in PD. Dr. Beatix Feigl and her colleagues developed a novel light therapy intervention that selectively activates the melanopsin photoreceptor cells, and in this episode, she discusses the results of a recent randomized controlled trial evaluating the efficacy of this melanopsin photoreceptor-directed light therapy on sleep and circadian rhythm, as well as motor behaviors. She also discusses her earlier work on melanopsin cells that led to the development of standard measures to assess their function. Beatrix is an Ophthalmologist and an Associate Professor in the School of Biomedical Sciences and Center for Vision and Eye Research, as well as the Faculty of Health, at the Queensland University of Technology.

Mentioned in this episode:

From now through December 2, you can help accelerate Parkinson’s research. This Giving Tuesday, all donations to The Michael J. Fox Foundation will be matched up to $4 million, which means your impact will be doubled. Visit michaeljfox.org/givetoresearch to be part of the cure.

This podcast episode was part of a limited series created by The Michael J. Fox Foundation in 2023 and 2024 for clinicians and researchers in our audience. These episodes provide a deeper dive into exciting new scientific research in Parkinson’s disease, as well as innovative tools and valuable resources, through conversations with a variety of experts in the field. We hope you enjoy the conversation.

  continue reading

256 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play